Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.

about

Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging Cognitive Dysfunction in Drug-induced Parkinsonism Caused by Prokinetics and Antiemetics Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism.

P2860

Q28550219-26548983-F6F2-4F33-92E6-13D3CA50B8AE Q36007885-FFBC7FE2-0242-48DF-8271-FAD5542DFCEA Q37620449-47F13FA4-D333-4830-82D5-4959D1D8FC5D

P2860

Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.

Item

http://www.wikidata.org/entity/Q48534930

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Clinical features of drug-indu ...... positron emission tomography.

@en

Clinical features of drug-indu ...... positron emission tomography.

@nl

type

Item

label

Clinical features of drug-indu ...... positron emission tomography.

@en

Clinical features of drug-indu ...... positron emission tomography.

@nl

prefLabel

Clinical features of drug-indu ...... positron emission tomography.

@en

Clinical features of drug-indu ...... positron emission tomography.

@nl

P1476

Clinical features of drug-indu ...... positron emission tomography.

@en

P2093

Hae-Won Shin

http://www.w3.org/2001/XMLSchema#string

Jae Seung Kim

http://www.w3.org/2001/XMLSchema#string

Juyeon Kim

http://www.w3.org/2001/XMLSchema#string

Mi-Jung Kim

http://www.w3.org/2001/XMLSchema#string

Minyoung Oh

http://www.w3.org/2001/XMLSchema#string

Sooyeoun You

http://www.w3.org/2001/XMLSchema#string

Sun Ju Chung

http://www.w3.org/2001/XMLSchema#string

Young Jin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.

Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.

Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia.

Levosulpiride-induced movement disorders.

DAT imaging in drug-induced and psychogenic parkinsonism.

Role of dopamine transporter imaging in routine clinical practice.

(18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism.

Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs.

Failure of recognition of drug-induced parkinsonism in the elderly.

The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.

P2888

s10072-014-1945-8

P304

269-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10072-014-1945-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25231645

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.

about

P2860

P2860

Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921